Skip to main content

Table 1 Patient characteristics (n = 194)

From: Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging

  Total
  n = 194
Age at time of PET/CT (years), median (IQR) 70.0 (63.0–75.0)
Most recent PSA prior to PET/CT (ng/mL), median (IQR) 10.0 (6.5–18.0)
PSA groups (ng/mL) (n = 194)  
  ≤10 101 (52.1%)
10 –20 50 (25.8%)
 > 20 43 (22.2%)
ISUP grade (n = 189)  
1 8 (4.2%)
2 41 (21.7%)
3 50 (26.5%)
4 34 (18.0%)
5 56 (29.6%)
Previous/current ADT prior to the PET/CT scan 14 (7.2%)
Duration of ADT prior to PET/CT scan (months), median (IQR) (n = 14) 2.0 (2.0–5.0)
  1. Data presented as median (IQR) for continuous variables and n (%) for categorical variables; n = number; ADT = Androgen Deprivation Therapy; IQR = interquartile range